These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8558921

  • 1. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
    Dirks W, Nolte M, Werner M, Jäger K, Koch C, Drexler HG.
    Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
    [Abstract] [Full Text] [Related]

  • 2. Sequence preservation of the third exon of the bcl-2 gene in non-Hodgkin's lymphoma: absence of somatic hypermutation.
    Farrugia MM, Duan LJ, Reis MD, Ngan BY, Sawka CA, Berinstein NL.
    Leukemia; 1995 Apr; 9(4):643-9. PubMed ID: 7723399
    [Abstract] [Full Text] [Related]

  • 3. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
    Steube KG, Jadau A, Teepe D, Drexler HG.
    Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
    Tanaka S, Louie DC, Kant JA, Reed JC.
    Blood; 1992 Jan 01; 79(1):229-37. PubMed ID: 1339299
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
    Chen W, Butler M, Rao PH, Chaganti SR, Louie DC, Dalla-Favera R, Chaganti RS.
    Oncogene; 1998 Oct 01; 17(13):1717-22. PubMed ID: 9796700
    [Abstract] [Full Text] [Related]

  • 8. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 9. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR, Chen W, Parsa N, Offit K, Louie DC, Dalla-Favera R, Chaganti RS.
    Genes Chromosomes Cancer; 1998 Dec 04; 23(4):323-7. PubMed ID: 9824205
    [Abstract] [Full Text] [Related]

  • 10. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
    Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML.
    N Engl J Med; 1988 Jun 23; 318(25):1638-44. PubMed ID: 3287162
    [Abstract] [Full Text] [Related]

  • 11. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ, van Krieken JH, Kluin-Nelemans HC, Kluin PM, Schuuring E.
    Oncogene; 1995 May 04; 10(9):1833-40. PubMed ID: 7753558
    [Abstract] [Full Text] [Related]

  • 12. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
    Kurata M, Maesako Y, Ueda C, Nishikori M, Akasaka T, Uchiyama T, Ohno H.
    Cancer Res; 2002 Nov 01; 62(21):6224-30. PubMed ID: 12414651
    [Abstract] [Full Text] [Related]

  • 13. High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma.
    Green M, Gandhi MK, Camilleri E, Marlton P, Lea R, Griffiths L.
    Leuk Res; 2009 May 01; 33(5):731-4. PubMed ID: 18929412
    [Abstract] [Full Text] [Related]

  • 14. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
    Kiem HP, Nourse J, Saltman DL, Blume KG, Cleary ML.
    Oncogene; 1990 Dec 01; 5(12):1815-9. PubMed ID: 2284100
    [Abstract] [Full Text] [Related]

  • 15. Follicular center cell lymphoma with the t(14;18) translocation in which the rearranged BCL-2 gene is silent.
    Wang J, Raffeld M, Medeiros LJ, Longo DL, Jaffe ES, Duffey P, Stetler-Stevenson M.
    Leukemia; 1993 Nov 01; 7(11):1834-9. PubMed ID: 7694006
    [Abstract] [Full Text] [Related]

  • 16. Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.
    Miyamura K, Kobayashi T, Sasaki T, Ibuka T, Imai K, Sakai Y, Kawaguchi K, Miyashita T, Iwaya M, Mizutani S.
    Int J Hematol; 1991 Apr 01; 54(2):137-40. PubMed ID: 1747446
    [Abstract] [Full Text] [Related]

  • 17. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ, Kluin PM.
    Oncogene; 1991 Dec 01; 6(12):2271-6. PubMed ID: 1766674
    [Abstract] [Full Text] [Related]

  • 18. Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene.
    Hua C, Zorn S, Jensen JP, Coupland RW, Ko HS, Wright JJ, Bakhshi A.
    Oncogene Res; 1988 Feb 01; 2(3):263-75. PubMed ID: 3285301
    [Abstract] [Full Text] [Related]

  • 19. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
    Cogliatti SB, Griesser H, Peng H, Du MQ, Isaacson PG, Zimmermann DR, Maibach RC, Schmid U.
    J Pathol; 2000 Dec 01; 192(4):470-8. PubMed ID: 11113864
    [Abstract] [Full Text] [Related]

  • 20. The bcl-2 gene and protein in malignant lymphomas.
    Cleary ML.
    Bull Cancer; 1991 Dec 01; 78(2):187-93. PubMed ID: 1903662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.